Amgen-Horizon Deal May Signal FTC’s Return To Bargaining
September 13, 2023
On Sept. 1, just over a week before trial was slated to begin, the Federal Trade Commission and several states agreed to settle their challenge to Amgen Inc.'s proposed acquisition of Horizon Therapeutics, allowing the transaction to close.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Concurrences New Frontiers of Antitrust Conference 2026
Sponsorship
Antitrust
Stakeholders 26th Annual CYOC Conference
Event
Antitrust
ALFDP 20th Anniversary Annual Conference
Event
Antitrust
GCR Live: Women in Antitrust 2026
Sponsorship
Antitrust
GICLI Annual Meeting 2026
Sponsorship
Antitrust
Informa CompLaw Advanced EU Conference 2026
Sponsorship
Antitrust
Wild Tomorrow 2026 Annual Gala
Sponsorship
Antitrust
NAPABA Annual Convention 2026
Sponsorship
Antitrust
Law.com General Counsel Conference East 2026
Sponsorship
Antitrust
Economist Enterprise's 1st Annual Antitrust Summit US
Sponsorship
Antitrust